López-López B, Pérez-López MJ, García-Rincón A, Vázquez-Vega B

Language: Spanish
References: 25
Page: 484-488
PDF size: 286.90 Kb.

ABSTRACT

Introduction: Current epidemiological transition from infectious to chronic-degenerative diseases is more and more demanding procedures requiring contrast medium, which turns out to be a risk factor for acute renal major damage in patients with chronic kidney disease. The aim of this article is to describe the frequency and evolution of Contrast-induced nephropathy in ambulatory patients with chronic kidney disease undergoing percutaneous coronary intervention.
Methods: We included patients with renal damage at the time of exposure to the contrast medium. They took a risk and were adjusted prevention measures follow at 48 hrs. Statistical analysis was performed using descriptive statistics.
Results: From 1236 cardiac catheterization procedure performed, 32 patients met the inclusion criteria. The 96.87% had chronic degenerative diseases such as diabetes or hypertension, overweight and obesity were a constant in 65.62% of cases, in 21.7% of patients the contrast dose was slightly higher than recommended. The 6.3% developed contrastinduced nephropathy with elevated creatinine greater than 25% at 48 hours after the procedure, despite preventive measures, however none of them required renal replacement.
Conclusions: The frequency of contrast medium-induced nephropathy in patients with high risk factors was lower than that reported in the literature; this may correspond to that in all cases nephrology assessment was performed before the procedure.

REFERENCES

1. Valdez R, Wong R, Flores E, Basoni A, Esquivel C, Gonzalez L,et al. Nefropatía por medio de contraste en angiografía cardiaca. Med Int Mex 2010;26(3): 226-236.

2. Arana E, Catalá F. Nefropatía inducida por contraste en pacientes de riesgo con insuficiencia renal explorados con tomografía computarizada: revisión sistemática y meta análisis de ensayos clínicos aleatorizados. Med Clin(Barc) 2010;135:343–350.

3. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, et al. N-Acetylcysteine and Contrast- Induced Nephropathy in Primary Angioplasty. N Engl J Med 2006;354:2773-82.

4. Kidney Disease Improving Global Outcomes. KDIGO Clinical Practice Guideline for Acute Kidney Injury: Contrast-induced AKI: definition, epidemiology, and prognosis. Kidney International Supplements (2012)2,69-88.

5. Sociedad Española de Nefrología. Guías SEN Actuación en el fracaso renal agudo: Definiciones de insuficiencia renal aguda. Nefrologia 2007;27 (Supl 2): 3-13.

6. Osorio M. Nefropatía inducida por medio de contraste endovenoso yodado. Anales de Radiología México 2011;1:21-26.

7. Balparda J, Gaviria M. Nefropatía inducida por medios de contraste radiológico yodados. IATREIA 2008;21:2-6.

8. Gleeson T and Bulugahapitiya S. Contrast-Induced Nephropathy. AJR 2004;183:1673-1689.

9. Aspelin P, Aubry P, Fransson G, Strasser R, Willenbrock R, Berg K. Nephrotoxic Effects in High-Risk Patients Undergoing Angiography. N Engl J Med 2003;348: 491-9.

10. Lee P, Chou K, Fang H. Preventing Contrast-Induced Nephropathy in Patients With Baseline Renal Dysfunction Undergoing Coronary Angiography.current treatment options in cardiovascular medicine 2009;11:71-78.

11. Cho J, Jeong M, Park S, Kim I, Park K, Sun Sim D, et al. Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure. Journal of Cardiology 2010;56:300-306.

12. McCullough P. Acute kidney injury with iodinated contrast. Crit Care Med 2008: 36, No. 4 (Suppl.)

13. Guideline for Percutaneous Coronary Intervention : A Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation journal of America Heart Association 2011; 124: 574-651.

14. Seeliger H, Sendeski M, Rihal M and Persson P. Contrast- induced kidney injury: mechanisms, risk factors, and prevention. European Heart Journal 2012.

15. Solomon R. Preventing contrast-induced nephropathy: problems, challenges and future directions. BMC Medicine 2009;7:1-24.

16. Calabro P, Bianchi R, Crisci M, et al. Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography. Intern Emerg Med (2011) 6:503-507.

17. Mehran R,Aymong E, Nikolsky E,*†, Lasic Z, Lakovou L, Fahy M, Mintz G, et al. A Simple Risk Score for Prediction of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention. JACC, 2004 Vol. 44, No. 7:1393-9.

18. Merten G, Burgess P, Holleman J, Roush T, Kowalchuk G, Bersin R, et al. Prevention of Contrast- Induced Nephropathy With Sodium Bicarbonate. JAMA. 2004;291:2328-2334.

19. Bello A, Kawar B, El Nahas M . Epidemiology and Pathophysiology of Chronic Kidney Disease En: Floege J, Johnson R, Feehally J As editors. Comprehensive Clinical Nephrology United States: elsevier. 4ta ed; cap 75. Pag 907-1018.

20. Masso E, Poch E. Prevención primaria y secundaria de la insuficiencia renal aguda. Nefroplus 2010; 3(2):1-15.

21. Lawrence A, Quesada R. Protocolo de n-acetilcisteina más hidratación en la prevención de la nefropatía por contraste. Revista médica de costa rica y Centroamérica LXIV 2007;(579) 63-69.

22. Waikar S and Bonventre J. Creatinine Kinetics and the Definition of Acute Kidney Injury. J Am Soc Nephrol 2009; 20:672-679.

23. Waikar S, Curhan G, Ayanian J and Chertow G. Race and Mortality after Acute Renal Failure J Am Soc Nephrol 2007; 18:2740-2748.

24. Chertow G, Burdick E, Honour M, Bonventre J and Bates D. Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients. J Am Soc Nephrol 2005; 16: 3365-3370.

25. Solomon R, Deray G. How to prevent contrast-induced nephropathy and manage risk patients: Practical recommendations. Kidney International 2006; 69:51-S53.